Massachusetts General Hospital compound targets HDAC11 for Alzheimer's disease Aug. 8, 2022 To explore the role of histone deacetylase 11 (HDAC11) in Alzheimer's disease, Massachusetts General Hospital researchers generated selective, brain-penetrating HDAC11 inhibitors.Read More
Dong-A ST compound DA-7503 potently inhibits tau aggregation Aug. 3, 2022 At the Alzheimer's Association International Conference, Dong-A ST scientists described preclinical research on a new tau-targeted agent, DA-7503.Read More
DS-17701585, EP300/CBP inhibitor with efficacy in lung squamous cell carcinoma xenograft July 8, 2022
[68Ga]NOTA-cc90 demonstrates imaging of LAG-3 expression on tumor-infiltrating lymphocytes June 29, 2022
RSS